TP53 and non-small cell lung carcinoma: Here, we applied clinically relevant multiple fractions of increasing doses of X-ray irradiation to obtain and characterize irradiation-surviving populations of two NSCLC cell lines—A549 (wild type p53) and H1299 (p53 null), and to investigate molecular mechanisms underlying their survival and radioresistance in relation to their p53 status.